Gabrielle Mengus
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Gabrielle Mengus has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
- Irwin Davidson
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France
64 shared publications - Guillaume Davidson
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France
42 shared publications - Alessandro Cuomo
Department of Experimental Oncology at IEO, European Institute of Oncology IRCCS , Milan 20139
39 shared publications - Eleonora Leucci
Laboratory of RNA Cancer Biology, Department of Oncology, LKI, KU Leuven, 3000 Leuven, Belgium
39 shared publications - Ewout Demesmaeker
Laboratory for RNA Cancer Biology, Department of Oncology, KU Leuven
39 shared publications - Gabriel G. Malouf
Department of Cancer and Functional Genomics, Institute of Genetics and Molecular and Cellular Biology, CNRS/INSERM/UNISTRA, Illkirch, France;
39 shared publications
Latest Publications
- Open Access
- 19 December 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Interaction of lncRNA LENT with DHX36 regulates translation and suppresses autophagy in melanoma
The melanocyte lineage-determining Microphthalmia-associated transcription factor (MITF) drives proliferation and survival of melanocytic melanoma cells through regulation of both coding genes and long non-coding RNAs (LncRNAs). Here we characterize LINC00520 (hereafter called L ncRNA ENhancer of T ranslation, LENT) regulated by MITF and strongly expressed in melanocytic melanoma cells. LENT is essential for the proliferation and survival of cultured melanocytic melanoma cells and xenograft tumors. LENT interacts with the G4 quadruplex resolvase DHX36, and both associate with the ribosome in the 80S and light polysome fractions. LENT modulates DHX36 association with a collection of mRNAs regulating their engagement with polysomes and fine-tuning their subsequent translation. These mRNAs encode proteins involved in endoplasmic reticulum (ER) and mitochondrial homeostasis as well as autophagy. Consequently, LENT silencing leads to extensive autophagy and mitophagy, compromised oxidative metabolic capacity, accompanied by an accumulation and mis-localization of mitochondrial proteins leading to proteotoxic stress and apoptosis. The LENT-DHX36 axis therefore fine-tunes translation of proteins involved in ER and mitochondrial homeostasis, suppressing autophagy and promoting survival and proliferation of melanoma cells.
- 19 December 2025
- Published by Springer Nature in Cell Death & Disease
- Vol. 17 (1)
Open AccessInteraction of lncRNA LENT with DHX36 regulates translation and suppresses autophagy in melanoma
The melanocyte lineage-determining Microphthalmia-associated transcription factor (MITF) drives proliferation and survival of melanocytic melanoma cells through regulation of both coding genes and long non-coding RNAs (LncRNAs). Here we characterize LINC00520 (hereafter called L ncRNA ENhancer of T ranslation, LENT) regulated by MITF and strongly expressed in melanocytic melanoma cells. LENT is essential for the proliferation and survival of cultured melanocytic melanoma cells and xenograft tumors. LENT interacts with the G4 quadruplex resolvase DHX36, and both associate with the ribosome in the 80S and light polysome fractions. LENT modulates DHX36 association with a collection of mRNAs regulating their engagement with polysomes and fine-tuning their subsequent translation. These mRNAs encode proteins involved in endoplasmic reticulum (ER) and mitochondrial homeostasis as well as autophagy. Consequently, LENT silencing leads to extensive autophagy and mitophagy, compromised oxidative metabolic capacity, accompanied by an accumulation and mis-localization of mitochondrial proteins leading to proteotoxic stress and apoptosis. The LENT-DHX36 axis therefore fine-tunes translation of proteins involved in ER and mitochondrial homeostasis, suppressing autophagy and promoting survival and proliferation of melanoma cells.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig-6 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
LENOX regulates RAP2 mitochondrial localisation
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig-6 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
LENOX regulates RAP2 mitochondrial localisation
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
Legends to Supplementary Figures and Tables
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
Legends to Supplementary Figures and Tables
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig-1 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
LENOX is associated with melanoma clinical features and regulated by TFAP2A.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig-1 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
LENOX is associated with melanoma clinical features and regulated by TFAP2A.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig-9 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
Ectopic LENOX expression increases oxidative phosphorylation in HEKT cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig-9 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
Ectopic LENOX expression increases oxidative phosphorylation in HEKT cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig-7 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
LENOX and RAP2C knockdown induce mitochondrial dysfunction, release of reactive oxygen species (ROS), DNA damage and cell cycle block
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig-7 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
LENOX and RAP2C knockdown induce mitochondrial dysfunction, release of reactive oxygen species (ROS), DNA damage and cell cycle block
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig-5 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
RAP2 paralog expression in melanoma cells
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig-5 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
RAP2 paralog expression in melanoma cells
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig-11 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
LENOX overexpression promotes resistance to BRAF and glycolysis inhibition.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig-11 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
LENOX overexpression promotes resistance to BRAF and glycolysis inhibition.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig-3 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
LENOX is required for xenograft growth
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig-3 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
LENOX is required for xenograft growth
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Fig-4 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
Gain of LENOX function stimulates melanoma cell proliferation
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig-4 from The LncRNA LENOX Interacts with RAP2C to Regulate Metabolism and Promote Resistance to MAPK Inhibition in Melanoma
Gain of LENOX function stimulates melanoma cell proliferation